MedDataX Logo

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

NCT ID: NCT05834270

Last Updated: 2023-04-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-01

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Single dose versus double dose tamsulosin in Management of Moderate and severe lower urinary tract symptoms due to benign prostatic hyperplasia

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostatic Neoplasms Prostate Disease Prostate Obstruction Prostate Hypertrophy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Tamsulosin Prostate

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single dose tamsulosin 0.4mg

Single dose tamsulosin 0.4mg

Group Type ACTIVE_COMPARATOR

Single dose tamsulosin 0.4mg

Intervention Type DRUG

Single dose tamsulosin 0.4mg

Double dose tamsulosin 0.4mg

Double dose tamsulosin 0.4mg

Group Type ACTIVE_COMPARATOR

Double dose tamsulosin 0.4mg

Intervention Type DRUG

Double dose tamsulosin 0.4mg

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Single dose tamsulosin 0.4mg

Single dose tamsulosin 0.4mg

Intervention Type DRUG

Double dose tamsulosin 0.4mg

Double dose tamsulosin 0.4mg

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age more than 50 years
* moderate to severe lower urinary tract symptoms

Exclusion Criteria

* prostatic cancer
* urethral stricture
* prostate surgery
* Neurogenic bladder
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Menoufia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed M. Hassan

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Medicine

Shibīn al Kawm, Menofia, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SD vs DD Tamsulosin

Identifier Type: -

Identifier Source: org_study_id